.jpg)
Search
- Jul 24
- 3 min
Health care analytics company Trilliant Health adds Bon Secours Mercy Health as a strategic investor
The investment will help the company accelerate the development of its predictive analytics platform.
- Jul 22
- 3 min
Alloy Therapeutics and Echo Investment join forces for the development of antibody therapeutics
Wheeler’s comprehensive discovery-to-IND programs are designed to provide emerging bioharma companies a faster and more predictable path...
- Jul 21
- 3 min
Nanopharm and Leyden Labs to jointly develop intranasal spray for respiratory viruses
“Leyden Labs is taking a really exciting approach to finding solutions for the broad-spectrum prophylactic protection against..."
- Jul 20
- 3 min
Forest Hills Lab receives FDA approval to proceed with a Phase 2 clinical trial for Parkinson's
“This is an important milestone for a disorder that remains largely unaddressed. Currently, there is no effective drug treatment for CNS...
- Jul 16
- 3 min
Puma Biotechnology and NCCN collaborate to research gastric and gastroesophageal cancers
he role of neratinib in gastric and gastroesophageal cancers as well as neurofibromatosis 2.
- Jul 14
- 4 min
NrX Pharmaceuticals and the Israel Institute for Biological Research join for Coronavirus vaccine
The BriLife™ vaccine (technical name VSV ΔG1) is based on a previous, FDA-approved vaccine platform...and targeted towards COVID-19...
- Jul 11
- 6 min
Phillip Morris Intl to acquire Vectura Group to expand its development in inhaled therapeutics
The market for inhaled therapeutics is large and growing rapidly, with significant potential for expansion into new application areas.
- Jul 9
- 4 min
Lazurite joins with the Center For Health Affairs to revolutionize smart surgical tools
Lazurite is dedicated to creating better outcomes for all participants in the healthcare system – patients, surgeons, staff and others.
- Jul 5
- 2 min
Sinomed collaborates with the National University of Galway for an assessment method for stenting
The trial will employ the newly patented, HT Supreme® Healing-Targeted Drug-Eluting Stent (DES), which has the potential to break new ground
- Jul 4
- 3 min
Standigm receives strategic investment from SK Chemicals for development of AI drug candidates
"This partnership will help us to commercialize our AI-driven drug candidates and enhance our ability and expertise in drug development...”
- Jun 30
- 2 min
Felix Biotechnology joins Biocogent to collaborate on research to develop ingredients for skincare
The research project will develop novel, chemical-free and safe solutions that can specifically target problematic skin bacteria
- Jun 29
- 3 min
Intertek and Globizz partner to bring regulatory services to device manufacturers in the US & Japan
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories...
- Jun 25
- 3 min
Lokavant and CMIC partner to launch machine learning powered clinical trial intelligence platform
CMIC, the first company to provide CRO services in Japan has over 28 years of pharma development experience in the Asia-Pacific region.
- Jun 19
- 4 min
BC Platforms and Cureduchenne partner to improve access to clinical data and discover biomarkers
BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine
- Jun 13
- 6 min
Verona Pharma and Nuance Pharma announce a $219 million collaboration to commercialize Ensifentrine
"Up to $179 million in potential clinical, regulatory, and commercial milestone payments plus tiered double-digit royalties..."
- Jun 11
- 10 min
Valo Health and Khosla Ventures to combine, raise $750 million to transform drug discovery
Valo is building a fully-integrated, end-to-end approach to developing drugs from discovery through approval.
- Jun 9
- 3 min
ImaBiotech joins Pyxant Labs to from a leading global bioanalytical service provider
ImaGiotech, a leading global bioanalytical services provider will provide a unique offering to pharmaceutical and cosmetic companies.
- Jun 7
- 8 min
One Medical (Nasdaq: ONEM) to acquire Iora Health to expand its addressable market
“We are delighted to announce plans to combine with Iora Health, a technology-powered primary care leader..."
- May 28
- 6 min
PDS Biotechnology partners with the Head and Neck Cancer Alliance to share treatment options
The incidence of head and neck cancer is increasing in the US, primarily due to rates of infection with human papillomavirus (HPV)
- May 26
- 2 min
Medical device manufacturer, NextPhase Medical Devices, acquires Proven Process Medical Devices
Proven Process expands NextPhase’s expertise in R&D, engineering, design and manufacturing of ttherapeutic and diagnostic devices.